Multiplex immunohistochemistry (mIHC) is revolutionizing cancer research by enabling the visualization of multiple biomarkers within a single tissue section. When paired with automation, AI, and ...

SANTA CLARA, Calif, & MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Agilent Technologies, Inc. (NYSE: A) today announced a partnership with Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company® ...

An appreciation of tissue complexity in disorders such as cancer has led researchers to develop multiplex immunohistochemistry methods (mIHC), where dozens of markers are assayed on a single slide.

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the launch of its SignalStar Multiplex IHC ...

The prognostic value of Sprouty2 protein in nonsmall cell lung cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a full text component.

Multiplex immunohistochemistry (IHC) technologies are powerful tools to visualize multiple markers in the same tissue sample. These techniques, which include tyramide signal amplification and cyclic ...

A novel molecular subtype of hepatocellular carcinoma based on the tumor purity and tumor microenvironment-related polygenic risk scores. Comparison of 3 PCR-based assays for microsatellite ...

“The immune response is really important for cancer control, but it was neglected for decades,” says Anna Wilkins, urological cancer consultant at The Royal Marsden and clinician scientist at The ...

Breast cancer is a highly aggressive disease linked to poor clinical outcomes. Understanding the complex tumor microenvironment (TME) would help to identify novel therapeutic targets to improve ...

Leica Biosystems, unveiled ChromoPlex III Triple Detection RUO, a chromogenic multiplex immunohistochemistry detection system engineered to simplify assay setup and reduce variability. ChromoPlex III ...

(RTTNews) - Agilent Technologies Inc. (A) said that it has partnered with Akoya Biosciences Inc. (AKYA) to develop multiplex-immunohistochemistry diagnostic solutions for tissue analysis and to ...